Cargando…
Pemphigus Foliaceus—Repeated Treatment With Rituximab 7 Years After Initial Response: A Case Report
Pemphigus foliaceus is an autoimmune skin disease mediated by autoantibodies directed against desmoglein-1 located in the upper epidermal layer. Rituximab, a monoclonal anit-CD20 antibody depleting b-cells, offers an effective treatment possibility for therapy-resistant pemphigus foliaceus. Here, we...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237918/ https://www.ncbi.nlm.nih.gov/pubmed/30474029 http://dx.doi.org/10.3389/fmed.2018.00315 |